CCRM
Shraddha Patel is an Operations Associate at CCRM since April 2023, previously serving as a Manufacturing Technician at Resilience from October 2021 to October 2022. Shraddha pursued a Master's degree in Medical Biotechnology at the University of Windsor from 2020 to 2021 after completing a Bachelor's degree at Amity University Jaipur from 2014 to 2018. Additionally, Shraddha gained experience as a Graduate Student at the University of Windsor from January 2020 to October 2021.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.